New and More Objective Way to Diagnose Mesothelioma
A study published in Cancers looked at a new way to diagnose malignant pleural mesothelioma (MPM). The usual way to diagnose MPM is through a biopsy or looking at fluid in the chest, but these methods are not very accurate. The researchers in this study used mass spectrometry-based proteomics to look for biomarkers that can pinpoint MPM in the body. Identifying Cancer MPM is a serious cancer that is linked to exposure to asbestos and is usually found late, making it hard to treat. Pleural mesothelioma occurs in about 2,000 people in the United States every year. The prognosis is poor, with a median survival rate of 12 months. Conventional treatment may include surgery, radiation therapy, and chemotherapy. Improving the…